Shenfu injection for blood vessel health in sepsis
Treatments studied
Part of Infections clinical trials.
This study tests whether a traditional Chinese medicine called Shenfu injection can improve the flexibility of the carotid artery in people with sepsis or septic shock. It may help doctors understand if this treatment can reduce complications from severe infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with sepsis or septic shock in the acute phase.
- You or your legal representative can sign a consent form.
- You do not have severe narrowing or plaque in your carotid arteries.
- You do not have serious heart, liver, or kidney disease, or other terminal conditions.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an herbal medicine called Shenfu Injection can improve blood flow regulation in patients with septic shock. It aims to help stabilize blood pressure and might reduce the need for vasopressors.
This trial tests whether Shenfu injection can help prevent heart muscle damage in people with septic shock. If you have septic shock, you may be able to join this study to see if this treatment helps protect your heart.
This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.
This study tests whether using ultrasound (heart imaging and blood-vessel scanning) helps doctors treat septic shock—a life-threatening blood infection—more effectively. The trial measures whether these imaging tools help guide fluid and medication decisions during resuscitation.
This study looks at how well the heart and blood vessels work together in people with sepsis or septic shock. It may help doctors understand heart function better during serious infections, which could lead to improved care.
This trial tests whether a herbal injection called Xuebijing, plus standard care, can improve recovery from sepsis. It aims to find new markers in the blood that may help predict how well the treatment works.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.